Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies, biochemicals, isotype controls, flow cytometry multi-color selectors, kits, loading controls, lysates, peptides, proteins, slides, tags and cell markers, and tools and reagents. Its products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics and nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells, as well as in drug discovery products and services. Abcam plc also engages in sales and distribution, and financing and investing activities, as well as sells its products online. It offers validated antibodies and other binders, and assays to the research and clinical communities to help advance the understanding of biology and causes of disease. Abcam plc was founded in 1998 and is headquartered in Cambridge, the United Kingdom.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
SymbolLON:ABC
CUSIPN/A
Phone+44-1223-696000
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins19.67%
Return on Equity15.03%
Return on Assets12.58%
Miscellaneous
EmployeesN/A
Outstanding Shares204,640,000
Abcam (LON:ABC) Frequently Asked Questions
What is Abcam's stock symbol?
Abcam trades on the London Stock Exchange (LON) under the ticker symbol "ABC."
How often does Abcam pay dividends? What is the dividend yield for Abcam?
Abcam declared a dividend on Monday, March 5th. Shareholders of record on Thursday, March 15th will be paid a dividend of GBX 3.42 per share on Thursday, April 12th. This represents a yield of 0.28%. The ex-dividend date is Thursday, March 15th. The official announcement can be accessed at this link. View Abcam's Dividend History.
What price target have analysts set for ABC?
6 brokers have issued 1-year price objectives for Abcam's shares. Their forecasts range from GBX 680 to GBX 1,230. On average, they anticipate Abcam's stock price to reach GBX 1,018.50 in the next twelve months. View Analyst Ratings for Abcam.
Who are some of Abcam's key competitors?
Some companies that are related to Abcam include Ablynx (ABLX), Sirtex Medical (SRX), Biotest (BIO), ProMetic Life Sciences (PLI), Theratechnologies (TH), Oxford BioMedica (OXB), BioTime (BTX), 22nd Century Group (XXII), Horizon Discovery (HZD), Ampio Pharmaceuticals (AMPE), Immupharma (IMM), Verona Pharma (VRP), Tiziana Life Sciences (TILS), Pfenex (PFNX), Asterias Biotherapeutics (AST), Tissue Regenix Group (TRX), Ergomed (ERGO) and Navidea Biopharmaceuticals (NAVB).
Who are Abcam's key executives?
Abcam's management team includes the folowing people:
- Mr. Alan Thomas Hirzel BS, MS, MBA, CEO & Exec. Director (Age 50)
- Mr. Gavin Hilary James Wood BA (Hons), ACA, CFO & Exec. Director (Age 48)
- Mr. Mark Bushfield Ph.D., Scientific Director
- Mr. Sean Hickey BSc, Chief Information Officer
- Ms. Suzanne E. Smith LLB (Hons), MBA, Chief Legal Officer & Company Sec.
Has Abcam been receiving favorable news coverage?
Press coverage about ABC stock has trended somewhat positive this week, Accern reports. Accern scores the sentiment of press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Abcam earned a coverage optimism score of 0.20 on Accern's scale. They also gave news articles about the company an impact score of 46.97 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near future.
How do I buy shares of Abcam?
Shares of ABC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Abcam's stock price today?
One share of ABC stock can currently be purchased for approximately GBX 1,283.
How big of a company is Abcam?
Abcam has a market capitalization of £2.60 billion.
How can I contact Abcam?
Abcam's mailing address is 330 Cambridge Science Park, CAMBRIDGE, CB4 0FL, United Kingdom. The company can be reached via phone at +44-1223-696000.
MarketBeat Community Rating for Abcam (ABC)
MarketBeat's community ratings are surveys of what our community members think about Abcam and other stocks. Vote "Outperform" if you believe ABC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ABC will underperform the S&P 500 over the long term. You may vote once every thirty days.
Abcam (LON:ABC) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
6 Wall Street analysts have issued ratings and price targets for Abcam in the last 12 months. Their average twelve-month price target is GBX 1,018.50The high price target for ABC is GBX 1,230 and the low price target for ABC is GBX 680. There are currently 1 sell rating, 4 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Hold | Hold | Hold | Hold |
| Consensus Rating Score: | 2.00 | 2.00 | 2.17 | 2.00 |
| Ratings Breakdown: | 1 Sell Rating(s)
4 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
4 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
4 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | GBX 1,018.50 | GBX 1,018.50 | GBX 1,009.33 | GBX 972.67 |
Abcam (LON:ABC) Consensus Price Target History
Abcam (LON:ABC) Analyst Ratings History
Show:
(Data available from 4/20/2016 forward)
Abcam (LON:ABC) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 3/5/2018 | | GBX 3.42 | 0.28% | 3/15/2018 | 3/15/2018 | 4/12/2018 |
| 9/11/2017 | | GBX 7.36 | 0.71% | 11/16/2017 | 11/16/2017 | 12/8/2017 |
| 3/6/2017 | | GBX 2.83 | 0.31% | 3/16/2017 | 3/16/2017 | 4/13/2017 |
| 9/12/2016 | | GBX 6.56 | 0.83% | 11/10/2016 | 11/10/2016 | 12/2/2016 |
| 3/7/2016 | | GBX 2.35 | 0.38% | 3/17/2016 | 3/17/2016 | 4/15/2016 |
| 9/14/2015 | | GBX 5.92 | 0.99% | 11/12/2015 | 11/12/2015 | 12/4/2015 |
| 9/9/2014 | | GBX 5.62 | 1.31% | 11/6/2014 | 11/6/2014 | 11/28/2014 |
| 3/4/2014 | | GBX 2.13 | 0.5% | 3/19/2014 | 3/19/2014 | 4/18/2014 |
(Data available from 1/1/2013 forward)
Abcam (LON ABC) Insider Trading and Institutional Ownership History
Abcam (LON ABC) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 9/21/2017 | Jonathan Simon Milner | Insider | Sell | 567,033 | GBX 1,017 | £5,766,725.61 | | |
| 9/14/2017 | Louise Patten | Insider | Buy | 1,636 | GBX 1,079 | £17,652.44 | | |
| 6/5/2017 | Mara G Aspinall | Insider | Buy | 2,700 | GBX 979 | £26,433 | | |
| 3/22/2017 | Alan Thomas Hirzel | Insider | Buy | 6,000 | GBX 809 | £48,540 | | |
| 3/20/2017 | Alan Thomas Hirzel | Insider | Buy | 6,000 | GBX 839 | £50,340 | | |
| 12/8/2016 | Mara G Aspinall | Insider | Buy | 298 | GBX 786 | £2,342.28 | | |
| 12/7/2016 | Alan Thomas Hirzel | Insider | Buy | 227 | GBX 792 | £1,797.84 | | |
| 12/2/2016 | P. Warwick | Insider | Sell | 30,000 | GBX 808 | £242,400 | | |
| 9/30/2016 | Louise Patten | Insider | Buy | 12,378 | GBX 836 | £103,480.08 | | |
| 9/19/2016 | Milner,Jonathan Simon | Insider | Sell | 20,361 | GBX 820 | £166,960.20 | | |
| 9/14/2016 | Ross,Michael | Insider | Buy | 954 | GBX 800 | £7,632 | | |
| 11/11/2015 | Hirzel,Alan Thomas | Insider | Buy | 3,335 | GBX 580 | £19,343 | | |
| 10/27/2015 | Iliffe,Jeffrey | Insider | Buy | 301 | GBX 599 | £1,802.99 | | |
| 9/18/2015 | Hirzel,Alan Thomas | Insider | Buy | 4,000 | GBX 615 | £24,600 | | |
| 3/26/2015 | Jonathan Simon Milner | Insider | Sell | 2,480,000 | GBX 465 | £11,532,000 | | |
(Data available from 1/1/2013 forward)
Abcam (LON ABC) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Abcam (ABC) Stock Rating Reaffirmed by Peel Hunt
www.americanbankingnews.com - April 9 at 9:55 AM |
| Abcam (ABC) Stock Rating Reaffirmed by JPMorgan Chase
www.americanbankingnews.com - April 9 at 1:00 AM |
| Abcam (ABC) Price Target Increased to GBX 946 by Analysts at JPMorgan Chase
www.americanbankingnews.com - April 8 at 10:16 PM |
| Abcam's (ABC) "Hold" Rating Reiterated at Peel Hunt
www.americanbankingnews.com - April 4 at 12:31 PM |
| Peel Hunt Reiterates Hold Rating for Abcam (ABC)
www.americanbankingnews.com - April 3 at 10:30 PM |
| Abcam Plc (ABC) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - March 31 at 3:38 AM |
| Abcam's (ABC) Neutral Rating Reaffirmed at JPMorgan Chase & Co.
www.americanbankingnews.com - March 30 at 2:20 PM |
| Abcam (ABC) Price Target Increased to GBX 1,100 by Analysts at Peel Hunt
www.americanbankingnews.com - March 28 at 6:32 PM |
| Abcam's (ABC) Hold Rating Reiterated at Peel Hunt
www.americanbankingnews.com - March 27 at 12:02 PM |
| Abcam's (ABC) "Hold" Rating Reaffirmed at Peel Hunt
www.americanbankingnews.com - March 26 at 12:04 AM |
| Abcam (ABC) Receives Neutral Rating from JPMorgan Chase & Co.
www.americanbankingnews.com - March 24 at 1:10 PM |
 | Why Abcam Plc (LON:ABC) Delivered An Inferior ROE Compared To The Industry
finance.yahoo.com - March 19 at 3:59 PM |
| Abcam (ABC) Price Target Raised to GBX 1,011 at JPMorgan Chase & Co.
www.americanbankingnews.com - March 15 at 9:08 AM |
| Abcam Plc (ABC) Plans Dividend of GBX 3.42
www.americanbankingnews.com - March 14 at 10:06 AM |
| Want To Invest In Abcam Plc (LON:ABC)? Here’s How It Performed Lately
finance.yahoo.com - March 12 at 10:04 AM |
| Abcam Plc (ABC) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - March 6 at 3:28 AM |
| Peel Hunt Reaffirms Hold Rating for Abcam (ABC)
www.americanbankingnews.com - March 5 at 11:48 PM |
| Abcam (ABC) Downgraded by Berenberg Bank
www.americanbankingnews.com - March 5 at 10:30 AM |
 | Global epigenetics market expected to be driven by increasing prevalence of cancer and other diseases in next 10 years
www.marketwatch.com - March 5 at 10:25 AM |
 | Abcam Hikes Interim Payout On Profit Growth And Revenue Forecast Boost
www.morningstar.co.uk - March 5 at 10:25 AM |
| Abcam (ABC) Rating Reiterated by Peel Hunt
www.americanbankingnews.com - February 27 at 12:08 AM |
| Is It Time To Sell Abcam Plc (LON:ABC) Based Off Its PE Ratio?
finance.yahoo.com - February 13 at 4:47 PM |
| Is Abcam Plc (LON:ABC) As Financially Strong As Its Balance Sheet Indicates?
finance.yahoo.com - January 22 at 5:27 PM |
| Abcam (ABC) Upgraded to Buy by Numis Securities
www.americanbankingnews.com - January 7 at 8:56 AM |
| Abcam (ABC) Receives "Hold" Rating from Peel Hunt
www.americanbankingnews.com - January 7 at 8:56 AM |
| Abcam (ABC) Given Buy Rating at Berenberg Bank
www.americanbankingnews.com - January 5 at 4:52 PM |
 | BRIEF-Abcam Says On Track TO DELIVER 10% FY CONSTANT CURRENCY REVENUE GROWTH
www.reuters.com - January 5 at 2:19 PM |
| Abcam's (ABC) Hold Rating Reaffirmed at Peel Hunt
www.americanbankingnews.com - December 31 at 12:02 PM |
| Abcam Plc (ABC) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - December 21 at 3:52 AM |
| Abcam Plc breached its 50 day moving average in a Bullish Manner : ABC-GB : December 12, 2017
finance.yahoo.com - December 12 at 11:49 AM |
| ETFs with exposure to Abcam Plc : November 27, 2017
finance.yahoo.com - November 27 at 3:25 PM |
| At £9.925, Is It Time To Buy Abcam Plc (AIM:ABC)?
finance.yahoo.com - November 27 at 6:43 AM |
| Abcam Plc (ABC) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - November 26 at 4:38 AM |
 | Immunochemicals Markets 2016-2024 - Global Strategic Business Report 2017
www.finanznachrichten.de - November 20 at 4:59 PM |
 | Global Immunochemicals Industry
www.bizjournals.com - November 17 at 3:15 PM |
| ETFs with exposure to Abcam Plc : November 16, 2017
finance.yahoo.com - November 16 at 3:33 PM |
| Abcam Plc (ABC) Plans Dividend of GBX 7.36
www.americanbankingnews.com - November 11 at 9:54 AM |
| Abcam Plc breached its 50 day moving average in a Bullish Manner : ABC-GB : November 6, 2017
finance.yahoo.com - November 6 at 4:03 PM |
| ETFs with exposure to Abcam Plc : November 6, 2017
finance.yahoo.com - November 6 at 4:02 PM |
| Abcam Plc :ABC-GB: Earnings Analysis: For the six months ended June 30, 2017 : November 2, 2017
finance.yahoo.com - November 2 at 8:22 PM |
 | Top 4 Inexpensive Mutual Funds for Global Growth in 2018 - Nasdaq
www.nasdaq.com - November 1 at 3:11 PM |
| ETFs with exposure to Abcam Plc : October 27, 2017
finance.yahoo.com - October 27 at 5:26 PM |
| Wasatch Sells More Than 1% Stake In ABCAM For About GBP23 Million (ALLISS)
www.morningstar.co.uk - October 17 at 3:17 PM |
| ETFs with exposure to Abcam Plc : October 17, 2017
finance.yahoo.com - October 17 at 3:17 PM |
| Abcam Chairman Leaves Role For Chief Executive Position In US
www.morningstar.co.uk - October 11 at 8:29 PM |
| Abcam Plc (ABC) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - October 7 at 2:52 AM |
| Global Multiplex Biomarker Imaging Market to Touch US$ 843 Mn by 2027 - Future Market Insights
www.marketwatch.com - October 4 at 8:08 AM |
| ETFs with exposure to Abcam Plc : October 3, 2017
finance.yahoo.com - October 3 at 3:08 PM |
| Abcam Plc :ABC-GB: Earnings Analysis: 2017 By the Numbers : September 29, 2017
finance.yahoo.com - October 2 at 3:06 PM |
| Abcam Plc (ABC) Price Target Increased to GBX 1,020 by Analysts at Peel Hunt
www.americanbankingnews.com - September 24 at 9:14 AM |
Abcam (LON:ABC) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Abcam (LON ABC) Stock Chart for Friday, April, 20, 2018
Loading chart…
